Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000238140

Medchemexpress LLC (2S)-2-[[3-cyclobutyl-5-(3,4,5-trifluorophenoxy)imidazo[4,5-b]pyridin-2-yl]methylamino]propanamide | 1233231-30-5 | 98.3% | 419.4 g/mol | C20H20F3N5O2 | 50MG
SDP

Supplier:  Medchemexpress LLC HY12507950MG

Encompass_Preferred

DSP-2230 (ANP-230) is an orally active inhibitor of voltage-gated sodium channels with activity against Nav1.7, Nav1.8, and Nav1.9. It is used in preclinical research to evaluate analgesic effects and sodium channel modulation in models of neuropathic pain. The compound is supplied as a solid with high purity and documented solubility and storage recommendations for both in vitro and in vivo applications.

  • Orally active inhibitor of Nav1.7, Nav1.8, and Nav1.9.
  • Suitable for in vitro and in vivo studies, with DMSO solubility ≥100 mg/mL.
  • High purity suitable for research use.
  • Supplied as a solid powder with recommended cold storage to maintain stability.
  • Documented molecular weight and formula support analytical characterization.

Catalog No. 50-002-38140


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.